every 6 hours. Oxycodone orders changed from 5 mg for verbal pain score (VPS 0-10) 1-4 and 10 mg for VPS 5-10 PO every 4 hours as needed to 2.5 mg for VPS 1-4 or 5 mg for VPS 5-10 every 4 hours as needed, with a nursing check 1 hour later to assess if the remainder of the dose (i.e. another 2.5 mg or 5 mg respectively) was desired by the patient. The same total 4 hourly dose, i.e. 5 or 10 mg, based on VPS, was unchanged with the new order-set. The primary outcome was opioid use in the first 48 hours. Secondary outcomes included peak and average VPS in first 48 hours, and incidence and treatment of postoperative nausea/vomiting (PONV) and pruritis. RESULTS: A total of 1050 women were evaluated (542 before and 508 after the order-set change). There was significantly reduced opioid use in the first 48 hours (median [IQR], .0] mg vs. After ¼ 4.4 [0-12.5] mg; P < 0.001) (Fig 1) . There was a statistically significant but trivial increase in average VPS (mean AE SD, Before ¼ 1.8 AE 1.0 vs. After ¼ 2.0 AE 1.3; P ¼ 0.01), and no difference in peak VPS. There was a significant reduction in the percentage of patients who reported and were treated for PONV (Fig 2) . CONCLUSION: This study of over 1000 patients found that splitting doses of oxycodone and allowing the patient to receive the remainder of the dose 1 hour later reduced 48-hour opioid use by over 50% after CD. This simple, patient-centered, opioid-reduction strategy did not compromise pain relief and should be further investigated and adopted in obstetric practices to reduce postpartum opioid consumption.
968 Cerclage for short cervix in twins? Systematic review and meta-analyses of randomized and non-randomized studies Jared T. Roeckner, Luis Sanchez-Ramos, Andrew Kaunitz University of Florida College of Medicine, Jacksonville, FL OBJECTIVE: To conduct a systematic review with meta-analyses of randomized and non-randomized studies regarding the efficacy of cervical cerclage placement for the prevention of preterm birth in women with twin pregnancies and a short cervical length. STUDY DESIGN: We conducted a literature search of PubMed, Medline, Embase, Cochrane, clinicaltrials.gov from inception until June 2018 for studies evaluating the efficacy of cerclage placement in women with twin pregnancies and a short cervical length detected on sonography in mid-trimester. Hand searches of references from included articles and abstracts from the SMFM meeting were also performed. Data were also obtained from published quantitative systematic reviews. Meta-analyses of randomized (RCTs) and nonrandomized studies (prospective and retrospective) were performed combined and separately. Subgroup analyses based on cervical length (< 25 and 15 mm) were also performed. The primary outcome was preterm delivery < 34 weeks. Data were abstracted and summary non-adjusted relative risks (RR) and 95% confidence (CI) and predictive intervals (PI) were calculated using a random-effects model. A priori, the protocol was developed and registered. RESULTS: Three RCTs (n¼49 twin gestations) and seven non-randomized studies (n¼616 twin gestations) met inclusion criteria. Combining both randomized and non-randomized trials, cerclage placement was not associated with a reduction in preterm delivery prior to 34 weeks in women with twin gestations and a short (RR 0.82; CI 0.62-1.07; PI 0.41 -1.63). Results from non-randomized trials showed uncertain evidence for a decrease in PTB <34 weeks (RR 0.76; CI 0.63-0.91; PI, 0.53-1.07) meaning that in 95% of future studies the risk may be reduced as much as 47% or increased as much as 7%. Results were similar for a subgroup <15mm. The results from RCTs (N¼3) showed increased risk of delivery <34 weeks in patients with CL 25mm and twin gestation (RR 2.19, . No evidence of efficacy was noted for the secondary outcomes of perinatal death, NICU admission, PTB less than 37, 28, 24 weeks (see table) . CONCLUSION: Results from randomized and non-randomized studies suggest that women with twin gestations and a short cervix (< 25 mm and 15 mm) do not benefit from cerclage placement. More data from RCTs are needed to clarify the role of cerclage placement in women with twin gestations and a short cervical length. OBJECTIVE: Cesarean section rates in the United States were on the rise from 1996 (20.7%) through 2009, peaking at 32.9%. In 2016, the rates declined for the fourth year in a row to 31.9%. We sought to determine differences in rates of cesarean section and trends over time associated with parity, BMI, age, and insurer. STUDY DESIGN: We conducted a retrospective cohort study of 14,396,536 singleton, non-anomalous, term gestations from 2010 through 2016 who underwent cesarean section. From there, the rates were stratified by parity, maternal age, BMI (normal weight (18.5-24.5), overweight (25-29.9), obese (30-34.4) and morbid obesity (>40)), and insurance provider (Medicaid, Champus/tricare, Indian Health Service (IHS), private, self-pay, and other government). Multivariate regression analyses and chi-square tests were employed for statistical comparisons and a p-value of less than 0.05 was used to indicate statistical significance. RESULTS: There has been a statistically significant decline in cesarean section rates for all singleton pregnancies (Table 1) . Rates declined for all nulliparous (27.4% to 25.2%) and prior cesarean sections (90.5% to 86.9%). All age pregnancies saw a reduction in rates, with advanced maternal age gestations exhibiting overall high prevalence rates (38.4% to 36.1%). Normal weight and overweight pregnancies both had overall lower rates with declining prevalence rates, while obese (30.3% to 28.5% and morbidly obese (40.5% to 38.4%) had overall higher rates, but still decreasing over time. Rates declined significantly for all insurers except for self-pay, which was not statistically significant, and other government payers, which had increasing rates over time (25.3% to 26.3%). CONCLUSION: Overall, cesarean section prevalence rates for all pregnancies have declined over time, though higher rates are seen in general for AMA, obese and morbidly obese gestations. Resources should be allocated to target cesarean rates in these higher-risk populations.
970 Improved patient satisfaction with tissue adhesive as compared to sterile strips after cesarean wound closure 
OBJECTIVE:
To determine if the use of tissue adhesive results in higher patient satisfaction as compared to sterile strips when used after closure of the cesarean skin incision. STUDY DESIGN: This was a planned follow up study to a randomized controlled trial of tissue adhesive versus sterile strip for cesarean delivery. The trial was an unblinded, multicenter randomized controlled trial to compare wound complications following use of tissue adhesive (2-octyl cyanoacrylate) versus sterile strips after closure of cesarean incision. Eligibility criteria included any cesarean delivery via Pfannenstiel skin incision. Subjects underwent a standardized protocol including preoperative antibiotics, skin preparation, closure of the subcutaneous space if ! 2cm and subcuticular closure. The primary outcome was wound complication defined as drainage, cellulitis, abscess, seroma, hematoma or isolated wound separation within 8 weeks of delivery. In this analysis, patient experience with the cesarean scar was assessed using a modified validated survey administered electronically or by phone between 6 and 8 weeks after delivery. The survey assessed scar pain, itchiness, color, stiffness, irregularity and overall satisfaction with the scar using a 10-point scale in which 1 represented the lowest symptom severity or highest satisfaction, and 10 represented the highest symptom severity or lowest satisfaction. Outcomes were evaluated using Student's t -test.
